Parents
Sign in to add mentor| Stephen R. Jennings | grad student | Drexel Medical School (Microtree) | |
| James M. Wilson | post-doc | Penn | |
| Mark Dudley | research scientist | National Cancer Institute (Plant Biology Tree) | |
| Steven A. Rosenberg | research scientist | (Neurotree) |
Collaborators
Sign in to add collaborator| Carl H. June | collaborator | ||
| Daniel J. Rader | collaborator | (Cell Biology Tree) | |
| Nicholas P. Restifo | collaborator | (Chemistry Tree) | |
| Luk H. Vandenberghe | collaborator |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fraietta JA, Lacey SF, Orlando EJ, et al. (2021) Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nature Medicine |
| Fraietta JA, Lacey SF, Orlando EJ, et al. (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nature Medicine |
| Xue Q, Bettini E, Paczkowski P, et al. (2017) Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response. Journal For Immunotherapy of Cancer. 5: 85 |
| Wang J, Dudley M, Choquette T, et al. (2016) An Innovative in Vitro Potency Assay Designed to Predict the Fate of Chimeric Antigen Receptors Modified T Cell Therapy Post Infusion in ALL Blood. 128: 5830-5830 |
| Xue C, Cerignoli F, Senyukov V, et al. (2016) Abstract B090: Evaluation of a novel impedance-based assay for label free and dynamic assessment of CAR-T constructs efficacy against B-cell leukemia and lymphoma Cancer Immunology Research. 4 |
| Zhang L, Morgan RA, Beane JD, et al. (2015) Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2278-88 |
| Robbins PF, Kassim SH, Tran TL, et al. (2015) A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1019-27 |
| Kochenderfer JN, Dudley ME, Kassim SH, et al. (2015) Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 540-9 |
| Tran TH, Scott K, Lee S, et al. (2015) Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials Blood. 126: 2659-2659 |
| Beane JD, Lee G, Zheng Z, et al. (2015) 77. Clinical Scale Zinc Finger Nuclease (ZFN)-Driven Gene-Editing of PD-1 in Tumor Infiltrating Lymphocytes (TIL) for the Potential Treatment of Metastatic Melanoma Molecular Therapy. 23: S33-S34 |